NEXTCURE, INC Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate
NEXTCURE, INC (NXTC) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate of 91.00% for the 6-month period ending 2026-06-30, per its S-4 filed 2026-08-18.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate · last filed 2026-08-18
- NEXTCURE, INC share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for the quarter ending 2026-03-31 was 90.80%, a 0.33% increase year-over-year.
- NEXTCURE, INC share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for the quarter ending 2025-03-31 was 90.50%, a 8.64% increase year-over-year.
- NEXTCURE, INC share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for the quarter ending 2024-03-31 was 83.30%, a 2.33% increase year-over-year.
- NEXTCURE, INC share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for the quarter ending 2023-03-31 was 81.40%, a 2.13% increase year-over-year.
- NEXTCURE, INC share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for fiscal 2023 was 81.40%.
- NEXTCURE, INC share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for fiscal 2021 was 79.70%.
- NEXTCURE, INC share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for fiscal 2019 was 69.70%, a 0.00% change from fiscal 2018.
- NEXTCURE, INC share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for fiscal 2018 was 69.70%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 91.00% S-4 · filed 2026-08-18 | ||||
| 2026-03-31 | 90.80% 10-Q · filed 2026-05-07 | ||||
| 2025-12-31 | 90.50% S-4 · filed 2026-08-18 | ||||
| 2025-09-30 | 90.50% 10-Q · filed 2025-11-05 | ||||
| 2025-06-30 | 90.50% S-4 · filed 2026-08-18 | ||||
| 2025-03-31 | 90.50% 10-Q · filed 2026-05-07 | ||||
| 2024-12-31 | 83.30% S-4 · filed 2026-08-18 | ||||
| 2024-09-30 | 83.30% 10-Q · filed 2025-11-05 | ||||
| 2024-06-30 | 83.30% 10-Q · filed 2025-08-07 | ||||
| 2024-03-31 | 83.30% 10-Q · filed 2025-05-01 | ||||
| 2023-12-31 | 81.40% 10-K · filed 2025-03-06 | ||||
| 2023-09-30 | 81.40% 10-Q · filed 2024-11-07 | ||||
| 2023-06-30 | 81.40% 10-Q · filed 2024-08-01 | ||||
| 2023-03-31 | 81.40% 10-Q · filed 2024-05-02 | ||||
| 2022-09-30 | 79.70% 10-Q · filed 2023-11-02 | ||||
| 2022-06-30 | 79.70% 10-Q · filed 2023-08-03 | ||||
| 2022-03-31 | 79.70% 10-Q · filed 2023-05-04 | ||||
| 2021-12-31 | 79.70% 10-K · filed 2023-03-02 | 79.69% 10-K · filed 2022-03-03 | |||
| 2021-09-30 | 79.70% 10-Q · filed 2022-11-03 | ||||
| 2021-06-30 | 79.70% 10-Q · filed 2022-08-04 | ||||
| 2021-03-31 | 79.70% 10-Q · filed 2022-05-05 | ||||
| 2020-03-31 | 69.70% 10-Q · filed 2021-05-06 | ||||
| 2019-12-31 | 69.70% 10-K · filed 2021-03-04 | ||||
| 2019-09-30 | 69.70% 10-Q · filed 2020-11-05 | ||||
| 2019-06-30 | 69.70% 10-Q · filed 2020-08-06 | ||||
| 2018-12-31 | 69.70% 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |